Little Rock law firm sues Pfizer over drugs.Emerson Poynter LLP LLP - Lower Layer Protocol , a law firm with offices in Little Rock, Houston and Seattle, has filed a lawsuit lawsuit: see procedure; tort. against pharmaceutical giant Pfizer Inc., saying the company misrepresented facts about the safety of two drugs, Celebrex Cel·e·brex
A trademark for the drug celecoxib.
Pharmacologic class: Nonsteroidal cyclooxygenase-2 (COX-2) inhibitor, nonsteroidal anti-inflammatory drug (NSAID)
and Bextra Bextra® Cardiology Bucindolol An investigational nonselective beta-blocker with vasodilating properties in phase III clinical trials for treating CHF, removed from the marketplace. .
Pfizer removed all marketing for Celebrex last week after questions were raised about the pain medication's safety. Emerson Poynter's lawsuit is the third Pfizer faces after disclosing that Celebrex and Bextra might increase the chances of heart problems in users.
Pfizer released a study that showed Celebrex users had double the chance of experiencing heart problems than patients taking a placebo placebo (pləsē`bō), inert substance given instead of a potent drug. Placebo medications are sometimes prescribed when a drug is not really needed or when one would not be appropriate because they make patients feel well taken care of. .
Emerson Poynter filed the lawsuit on behalf of shareholders who purchased Pfizer stock between Nov. 1, 2000, and Dec. 16, 2004.
Emerson Poynter; whose Little Rock offices are at 2228 Cottondale Ave., was founded by partners John G. Emerson and Scott E. Poynter, both Arkansas natives. The firm specializes in securities purchaser class-action lawsuits.